"They told me I was overreacting," Freeberg told TechCrunch. But a little less than 12 months later, he was diagnosed with Stage 3a cancer, and it became evident that the incident was the beginning of the disease. "If they detected my cancer earlier, I could have avoided multiple surgeries and maybe even a chemotherapy regimen."
"Treating cancer is employers' top healthcare cost now," Freeberg said, adding that investing in startups that help decrease expenses and improve outcomes is a significant opportunity.
Unlike other cancer-focused VC firms, including Reed Jobs' Yosemite, which raised $200 million for its debut fund last year, Oncology Ventures doesn't invest in drug discovery. The firm is focused on startups that improve care with the help of data and tackle challenges from early detection to choosing optimal treatment plans.
Six and a half years after his diagnosis, Freeberg closed the inaugural Oncology Ventures fund with $30 million in committed capital.
Collection
[
|
...
]